These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 1611677)

  • 1. Synthesis and pharmacology of 3,4-dihydro-3-oxo-1,4-benzoxazine-8-carboxamide derivatives, a new class of potent serotonin-3 (5-HT3) receptor antagonists.
    Kawakita T; Kuroita T; Yasumoto M; Sano M; Inaba K; Fukuda T; Tahara T
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):624-30. PubMed ID: 1611677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzoxazines. II. Synthesis, conformational analysis, and structure--activity relationships of 3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide derivatives as potent and long-acting serotonin-3 (5-HT3) receptor antagonists.
    Kuroita T; Marubayashi N; Sano M; Kanzaki K; Inaba K; Kawakita T
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2051-60. PubMed ID: 8945770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of 6-chloro-3,4-dihydro-4-methyl-2H-1,4-benzoxazine-8-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
    Kuroita T; Sakamori M; Kawakita T
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):756-64. PubMed ID: 8681408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.
    Hayashi H; Miwa Y; Ichikawa S; Yoda N; Miki I; Ishii A; Kono M; Yasuzawa T; Suzuki F
    J Med Chem; 1993 Mar; 36(5):617-26. PubMed ID: 8496941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist.
    Fukuda T; Setoguchi M; Inaba K; Shoji H; Tahara T
    Eur J Pharmacol; 1991 Apr; 196(3):299-305. PubMed ID: 1654255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic activity of Y-25130 on 5-HT3 receptors.
    Sato N; Sakamori M; Haga K; Takehara S; Setoguchi M
    Jpn J Pharmacol; 1992 Aug; 59(4):443-8. PubMed ID: 1331590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of 2,3-dihydrobenzofuran-7-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
    Kuroita T; Yasumoto M; Inaba K; Sakamori M; Takehara S; Kawakita T
    Chem Pharm Bull (Tokyo); 1994 Jan; 42(1):95-100. PubMed ID: 8124772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
    Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
    J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of 5-HT3 receptor-mediated currents in dissociated frog sensory neurones by benzoxazine derivative, Y-25130.
    Yakushiji T; Akaike N
    Br J Pharmacol; 1992 Nov; 107(3):853-7. PubMed ID: 1472977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists.
    Turconi M; Nicola M; Quintero MG; Maiocchi L; Micheletti R; Giraldo E; Donetti A
    J Med Chem; 1990 Aug; 33(8):2101-8. PubMed ID: 1695682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 5-HT3 (serotonin-3) receptor antagonists. V. Synthesis and structure-activity relationships of pyrrolo[2,1-c][1,4]benzoxazine-6-carboxamides.
    Kato M; Nishino S; Ito K; Yamakuni H; Takasugi H
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1358-63. PubMed ID: 7553981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
    Fernández AG; Puig J; Beleta J; Doménech T; Bou J; Berga P; Gristwood RW; Roberts DJ
    Eur J Pharmacol; 1992 Nov; 222(2-3):257-64. PubMed ID: 1451737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
    Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged anti-emetic activity and 5-HT3-receptor antagonism by BRL 46470 in conscious ferrets.
    Bermudez J; Sanger GJ
    J Pharm Pharmacol; 1994 Jun; 46(6):520-1. PubMed ID: 7932054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships.
    Robertson DW; Lacefield WB; Bloomquist W; Pfeifer W; Simon RL; Cohen ML
    J Med Chem; 1992 Jan; 35(2):310-9. PubMed ID: 1732548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition by Y-25130 of the von Bezold-Jarisch effect evoked by 5-HT or 2-methyl-5-HT in anesthetized rats].
    Inaba K; Morimoto Y; Fukuda T; Setoguchi M
    Nihon Yakurigaku Zasshi; 1991 Oct; 98(4):293-9. PubMed ID: 1802816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides.
    Youssefyeh RD; Campbell HF; Klein S; Airey JE; Darkes P; Powers M; Schnapper M; Neuenschwander K; Fitzpatrick LR; Pendley CE
    J Med Chem; 1992 Mar; 35(5):895-903. PubMed ID: 1312602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 5-HT3 (serotonin-3) receptor antagonists. IV. Synthesis and structure-activity relationships of azabicycloalkaneacetamide derivatives.
    Kato M; Ito K; Nishino S; Yamakuni H; Takasugi H
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1351-7. PubMed ID: 7553980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Y-25130, a selective 5-HT3 receptor antagonist, on the intestinal fluid secretion in rats].
    Ooe M; Asano K; Haga K; Setoguchi M
    Nihon Yakurigaku Zasshi; 1993 May; 101(5):299-307. PubMed ID: 8330800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzimidazolone derivatives act as 5-HT4 receptor ligands in rat oesophagus.
    Baxter GS; Clarke DE
    Eur J Pharmacol; 1992 Mar; 212(2-3):225-9. PubMed ID: 1601064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.